Fistula Tract Cancer Survey

4 Perceptions & Concerns

4.1. Do you have any concerns regarding fistula tract cancer when you perform minimally invasive fistula procedures, such as FiLaC and VAAFT? (Check all that apply) *

Yes, concern about missing a malignancy

Yes, concern about causing or worsening cancer spread

Yes, concern about inadequate diagnostic assessment pre-procedure

Yes, concern about delayed diagnosis due to conservative management

No concerns

Other (please specify)

5 Risk Factors

5.1. In your opinion, which of the following factors may increase the risk of developing fistula tract cancer? (Select all that apply) *

Chronic fistula or long-standing fistulous disease (of about 10 years)

Previous surgical interventions or treatments for the same fistula

Presence of Crohn's disease or other inflammatory bowel diseases

Recurrent infections or abscesses in the anal region

Smoking

Poorly controlled diabetes or other immunocompromising conditions

Lack of adequate follow-up or delayed diagnosis

Precancerous lesions in the anogenital region (HPV)

Other (please specify)

6 Management Strategy

6.1. All cases of fistula cancer should be discussed at the MDT *

Agree

Disagree

6.2. What would be your preferred treatment option for fistula tract cancer? *

Chemo-Radiation Therapy

Local resection

Neoadjuvant radiation and Chemotherapy with or without APR

Upfront APR

Palliation

7 Additional Insights

7.1. Please share any insights or experiences related to fistula tract cancer.

Thank you for your participation!

Your responses have been successfully submitted and will contribute to better understanding of fistula tract cancer.

Submission Error

There was an error submitting your survey. Please try again.